Use of mnk inhibitors for the treatment of alzheimer's disease

Details Use of mnk inhibitors for the treatment of alzheimer's disease Use of mnk inhibitors for the treatment of alzheimer's disease

A - Human Necessities

61

K

A61K 31/519 (2006.01) A61P 25/28 (2006.01) G01N 33/15 (2006.01)

Patent

CA 2706203

The present invention relates to the use of modulators of the kinase activity of Mnk1 and/or Mnk2 the diagnosis, alleviation, treatment and/or prevention of a tauopathy. Particularly, the present invention relates to the use of a modulator of Mnk1 and/or Mnk2 kinase for the diagnosis, alleviation, treatment and/or prevention of Alzheimer's disease.

La présente invention concerne l'utilisation de modulateurs de l'activité kinasique de la Mnk1 et/ou de la Mnk2 pour diagnostiquer, soulager, traiter et/ou prévenir une tauopathie. En particulier, la présente invention concerne l'utilisation d'un modulateur de la kinase Mnk1 et/ou Mnk2 pour diagnostiquer, soulager, traiter et/ou prévenir la maladie d'Alzheimer.

Affiliated with

Also associated with

Rating

Use of mnk inhibitors for the treatment of alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of mnk inhibitors for the treatment of alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of mnk inhibitors for the treatment of alzheimer's disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2037155